Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today is hostin
Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024
08:00am, Monday, 19'th Aug 2024
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, will host an In
Marinus Pharmaceuticals, Inc. (MRNS) Q2 2024 Earnings Call Transcript
02:17pm, Tuesday, 13'th Aug 2024
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Sonya Weigle - Chief People and Investor Relations Officer Scott Braunstei
Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Misses Revenue Estimates
09:11am, Tuesday, 13'th Aug 2024
Marinus Pharmaceuticals (MRNS) came out with a quarterly loss of $0.60 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $0.61 per share a year ago.
Pacific Defense Announces US Army CMFF Program Team
07:01am, Tuesday, 13'th Aug 2024
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Pacific Defense, a leading provider of Modular Open Systems Approach (MOSA) products and mission solutions, announced their team to compete for the U.S. Army's CMO
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results
07:00am, Tuesday, 13'th Aug 2024
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported
Investors Are Invited To Participate In The Marinus Pharmaceuticals Inc Fraud Investigation With The Schall Law Firm
06:00pm, Wednesday, 07'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceuticals, Inc. ("Marinus" or "the Company") (NASD
MRNS Investors Have Opportunity To Join Marinus Pharmaceuticals Inc Fraud Investigation With The Schall Law Firm
05:45pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmace
3 Biotech Stocks to Sell in August Before They Crash & Burn
08:00am, Tuesday, 06'th Aug 2024
For investors, one of the most attractive aspects of biotech stocks is their ability to increase in value in a short period of time quickly. After all, it only takes one major breakthrough in clinical
Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRNS
02:15pm, Monday, 05'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securi
August 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNS
12:48pm, Monday, 05'th Aug 2024
NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ: MRNS) of a class action securities lawsuit.
Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) Seeking Recovery for Investors - Contact Levi & Korsinsky
12:45pm, Monday, 05'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securi
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securi
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmac
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securi
